NOVARTIS AG-SPONSORED ADR (NVS)
US66987V1098 - ADR
NOVARTIS AG-SPONSORED ADR
NYSE:NVS (4/25/2024, 6:00:00 PM)
After market: 99.06 0 (0%)99.06
+0.71 (+0.72%)
Company Profile
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 101,703 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Company Info
NOVARTIS AG-SPONSORED ADR
Lichtstrasse 35
Basel BASEL-STADT CH 4056
P: 41613241111
CEO: Vasant (Vas) Narasimhan
Employees: 101703
Website: https://www.novartis.com/
NVS News
11 hours ago - Investor's Business DailyWhy Big Pharma Is Following Novartis' Lead In A $25 Billion MarketThe radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
2 days ago - The Motley FoolWhy Novartis Stock Topped the Market on TuesdayA double beat on the latest quarterly results and raised guidance made investors happy.
A double beat on the latest quarterly results and raised guidance made investors happy.
2 days ago - InvestorPlaceNVS Stock Earnings: Novartis Beats EPS, Beats Revenue for Q1 2024NVS stock results show that Novartis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
2 days ago - The Motley FoolNovartis Ag (NVS) Q1 2024 Earnings Call TranscriptNVS earnings call for the period ending March 31, 2024.
2 days ago - CNBCJim Cramer shares his thoughts on RTX, Pepsi, Nucor, Novartis and Cadence Design SystemsDuring the Investing Club's Morning Meeting, Jim Cramer offered his thoughts on recent earnings from RTX, PepsiCo, Nucor, Novartis and Cadence Design Systems.
NVS Twits
Here you can normally see the latest stock twits on NVS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
